Post-approval studies (Phase 4)Not Yet RecruitingNCT07059130
What this trial is testing
Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis
Who this might be right for
Crohn Disease (CD)Crohns DiseaseUlcerative Colitis (UC)
Rubix LS 150